{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:01:21Z","timestamp":1771326081414,"version":"3.50.1"},"reference-count":27,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2020,3,31]]},"DOI":"10.18632\/oncotarget.27425","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T13:57:36Z","timestamp":1586181456000},"page":"1097-1108","source":"Crossref","is-referenced-by-count":21,"title":["Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma"],"prefix":"10.18632","volume":"11","author":[{"given":"Yetirajam","family":"Rajesh","sequence":"first","affiliation":[{"name":"School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angana","family":"Biswas","sequence":"additional","affiliation":[{"name":"School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payel","family":"Banik","sequence":"additional","affiliation":[{"name":"School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ipsita","family":"Pal","sequence":"additional","affiliation":[{"name":"School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhayan","family":"Das","sequence":"additional","affiliation":[{"name":"School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin A.","family":"Borkar","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery & Gamma Knife, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hardik","family":"Sardana","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery & Gamma Knife, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Saha","sequence":"additional","affiliation":[{"name":"Radiation Department, UGC DAE Consortium, Jadavpur University, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swadesh K.","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"},{"name":"VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"},{"name":"VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luni","family":"Emdad","sequence":"additional","affiliation":[{"name":"Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"},{"name":"VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"},{"name":"VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"},{"name":"VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"},{"name":"VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahitosh","family":"Mandal","sequence":"additional","affiliation":[{"name":"School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India"},{"name":"Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"},{"name":"VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/aps.2016.167","article-title":"Insights into molecular therapy of glioma: current challenges and next generation blueprint","volume":"38","author":"Mandal","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1021\/acschemneuro.9b00016","article-title":"Rethinking glioblastoma therapy: MDA 9\/Syntenin targeted small molecule","volume":"10","author":"Fisher","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/neuonc\/not157","article-title":"MDA-9\/syntenin is a key regulator of glioma pathogenesis","volume":"16","author":"Sarkar","year":"2014","journal-title":"Neuro Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.yexcr.2017.08.032","article-title":"Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition","volume":"359","author":"Mandal","year":"2017","journal-title":"Exp Cell Res"},{"key":"5","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.bbagen.2019.04.015","article-title":"Delineation of crosstalk between HSP27 and MMP-2\/MMP-9: A synergistic therapeutic avenue for glioblastoma management","volume":"1863","author":"Mandal","year":"2019","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.18632\/aging.100795","article-title":"Hypoxia and glioblastoma therapy","volume":"7","author":"Zhuang","year":"2015","journal-title":"Aging (Albany NY)"},{"key":"7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0008-6363(01)00198-5","article-title":"Hypoxia induces heat shock protein expression in human coronary artery bypass grafts","volume":"50","author":"Dirnhofer","year":"2001","journal-title":"Cardiovasc Res"},{"key":"8","doi-asserted-by":"publisher","first-page":"e1650","DOI":"10.1038\/cddis.2015.8","article-title":"Ets-1 as an early response gene against hypoxia-induced apoptosis in pancreatic \u03b2-cells","volume":"6","author":"Han","year":"2015","journal-title":"Cell Death Dis"},{"key":"9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/sj.bjc.6605227","article-title":"Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement","volume":"101","author":"Cuzick","year":"2009","journal-title":"Br J Cancer"},{"key":"10","doi-asserted-by":"publisher","first-page":"6432","DOI":"10.1038\/sj.onc.1204039","article-title":"Expression and function of Ets transcription factors in mammalian development: a regulatory network","volume":"19","author":"Bowe","year":"2000","journal-title":"Oncogene"},{"key":"11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0378-1119(02)01156-3","article-title":"Molecular biology of the Ets family of transcription factors","volume":"303","author":"Yamada","year":"2003","journal-title":"Gene"},{"key":"12","first-page":"551","article-title":"Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma","volume":"7","author":"Nesland","year":"2001","journal-title":"Clin Cancer Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrc.2017.20","article-title":"The ETS family of oncogenic transcription factors in solid tumours","volume":"17","author":"Ostrowski","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0092-8674(91)90428-2","article-title":"Friend virus-induced erythroleukemia and the multistage nature of cancer","volume":"66","author":"Bernstein","year":"1991","journal-title":"Cell"},{"key":"15","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1349-7006.2004.tb03320.x","article-title":"ETS transcription factors: Possible targets for cancer therapy","volume":"95","author":"Oikawa","year":"2004","journal-title":"Cancer Sci"},{"key":"16","doi-asserted-by":"publisher","first-page":"143952","DOI":"10.1016\/j.gene.2019.143952","article-title":"Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor","volume":"711","author":"Hussain","year":"2019","journal-title":"Gene"},{"key":"17","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cub.2008.07.048","article-title":"Fli1 Acts at the top of the transcriptional network driving blood and endothelial development","volume":"18","author":"Patient","year":"2008","journal-title":"Curr Biol"},{"key":"18","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1128\/MCB.20.15.5643-5652.2000","article-title":"Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor","volume":"20","author":"Watson","year":"2000","journal-title":"Mol Cell Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.14670\/HH-23.1309","article-title":"Fli-1 expression in malignant melanoma","volume":"23","author":"Bilalovic","year":"2008","journal-title":"Histol Histopathol"},{"key":"20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/1471-2407-14-424","article-title":"Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer","volume":"14","author":"Cui","year":"2014","journal-title":"BMC Cancer"},{"key":"21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3109\/07357907.2015.1069831","article-title":"Overexpression of Fli-1 is associated with adverse prognosis of endometrial cancer","volume":"33","author":"Cui","year":"2015","journal-title":"Cancer Invest"},{"key":"22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neo.2014.08.007","article-title":"FLI1 Expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression","volume":"16","author":"Watson","year":"2014","journal-title":"Neoplasia"},{"key":"23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tranon.2014.04.015","article-title":"Friend leukemia virus integration 1 expression has prognostic significance in nasopharyngeal carcinoma","volume":"7","author":"Xie","year":"2014","journal-title":"Transl Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2019.03.025","article-title":"Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma","volume":"164","author":"Mandal","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cellsig.2017.03.017","article-title":"Therapeutic implication of \u2018Iturin A\u2019 for targeting MD-2\/TLR4 complex to overcome angiogenesis and invasion","volume":"35","author":"Mandal","year":"2017","journal-title":"Cell Signal"},{"key":"26","doi-asserted-by":"publisher","first-page":"10316","DOI":"10.1038\/srep10316","article-title":"Marine lipopeptide Iturin A inhibits Akt mediated GSK3\u03b2 and FoxO3a signaling and triggers apoptosis in breast cancer","volume":"5","author":"Mandal","year":"2015","journal-title":"Sci Rep"},{"key":"27","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1016\/j.bbagen.2016.10.004","article-title":"Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy","volume":"1861","author":"Mandal","year":"2017","journal-title":"Biochim Biophys Acta Gen Subj"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T20:48:00Z","timestamp":1591390080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":27,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,3,31]]}},"alternative-id":["27425","32284788"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27425","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]}}}